Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Lago

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Inflammatory Bowel Diseases|November 20, 2009
Ulcerative colitis in northern Portugal and Galicia in SpainManuel Barreiro-de Acosta, Fernando Magro, Daniel Carpio, et al.
Clinical and Translational Gastroenterology|May 1, 2020
Genetic Variants of the MGAT5 Gene Are Functionally Implicated in the Modulation of T Cells Glycosylation and Plasma IgG Glycome Composition in Ulcerative ColitisMárcia S Pereira, Cecília Durães, Telmo A Catarino, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Clinical practice in Crohn's disease in bordering regions of two countries: different medical options, distinct surgical eventsFernando Magro, Manuel Barreiro-de Acosta, Paula Lago, et al.
Inflammatory Bowel Diseases|February 25, 2009
Crohn's disease in a southern European country: Montreal classification and clinical activityFernando Magro, Francisco Portela, Paula Lago, et al.
Therapeutic Advances in Gastroenterology|September 14, 2019
Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumabFernando Magro, Susana Lopes, Marco Silva, et al.
Journal of Crohn'S & Colitis|May 27, 2016
Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving InfliximabFernando Magro, Susana Isabel Lopes, Joanne Lopes, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2023
Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximabPaula Sousa, Marta Patita, Bruno Arroja, et al.
Inflammatory Bowel Diseases|October 14, 2009
Ulcerative colitis in a Southern European country: a national perspectiveFrancisco Portela, Fernando Magro, Paula Lago, et al.
Scandinavian Journal of Gastroenterology|May 28, 2020
Methylation patterns in dysplasia in inflammatory bowel disease patientsIsadora Rosa, Patrícia Silva, Sara da Mata, et al.
Journal of Crohn'S & Colitis|March 15, 2025
T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel diseaseEduarda Leite-Gomes, Mariana C Silva, Ana M Dias, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Inflammatory Bowel Diseases|November 20, 2009
Ulcerative colitis in northern Portugal and Galicia in SpainManuel Barreiro-de Acosta, Fernando Magro, Daniel Carpio, et al.
Clinical and Translational Gastroenterology|May 1, 2020
Genetic Variants of the MGAT5 Gene Are Functionally Implicated in the Modulation of T Cells Glycosylation and Plasma IgG Glycome Composition in Ulcerative ColitisMárcia S Pereira, Cecília Durães, Telmo A Catarino, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Clinical practice in Crohn's disease in bordering regions of two countries: different medical options, distinct surgical eventsFernando Magro, Manuel Barreiro-de Acosta, Paula Lago, et al.
Inflammatory Bowel Diseases|February 25, 2009
Crohn's disease in a southern European country: Montreal classification and clinical activityFernando Magro, Francisco Portela, Paula Lago, et al.
Therapeutic Advances in Gastroenterology|September 14, 2019
Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumabFernando Magro, Susana Lopes, Marco Silva, et al.
Journal of Crohn'S & Colitis|May 27, 2016
Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving InfliximabFernando Magro, Susana Isabel Lopes, Joanne Lopes, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2023
Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximabPaula Sousa, Marta Patita, Bruno Arroja, et al.
Inflammatory Bowel Diseases|October 14, 2009
Ulcerative colitis in a Southern European country: a national perspectiveFrancisco Portela, Fernando Magro, Paula Lago, et al.
Scandinavian Journal of Gastroenterology|May 28, 2020
Methylation patterns in dysplasia in inflammatory bowel disease patientsIsadora Rosa, Patrícia Silva, Sara da Mata, et al.
Journal of Crohn'S & Colitis|March 15, 2025
T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel diseaseEduarda Leite-Gomes, Mariana C Silva, Ana M Dias, et al.
Pageof 9